Increasing R&D Expenditure in Biopharmaceuticals Driving Growth in Primary Cells Market

Pune, India, 2020-Jul-08 — /EPR Network/ —

According to the new market research report “Primary Cells Market by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Life Science Research & Research Institutes) – Global Forecast” published by MarketsandMarkets™

 The primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 666.0 million in 2017 at a CAGR of 8.5% from 2018–2023. The base year for this study is 2017 and the forecast period is 2018–2023.

Growth in the primary cells market is mainly driven by factors such as increasing cancer research; the advantages of primary human cells over cell lines; the increasing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries, partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing.

Browse 106 market data Tables and 126 Figures spread through 273 Pages and in-depth TOC – Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung, renal, heart, skeletal & muscle, and other primary cells. The liver cells segment is expected to register the highest CAGR during the forecast period due to their increasing demand in toxicological and pharmacological studies.

Primary Cells Market, By Type

1. Human Primary Cells
2. Animal Primary Cells

Based on type, the market is segmented into human and animal primary cells. The human primary cells segment is expected to register the highest CAGR during the forecast period owing to the high adoption of human primary cells in the development of novel cancer therapies. Human primary cells are also extensively used for studying human cancerous cell models, in toxicology studies, and in the cosmetic industry.

Regional Growth, Development and Demand Analysis:

The global primary cells market is dominated by North America, followed by Europe. North America will continue to dominate the global primary cells market during the forecast period, however, Asia is expected to witness the highest CAGR, with the growth in this market centered on China and Japan. Increasing number of players launching new human primary cells for research, expansion of pharmaceutical and biotechnology industries, and increasing prevalence of cancer in the region are the major factors driving the growth of the North American market.

Key Market Players

The major players in this market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK).

Request Sample Report of Primary Cells Market : https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960

The objectives of this study are as follows:

• To define, describe, and forecast the primary cells market by origin, type, end user and region
• To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To identify micromarkets and the drivers, opportunities, and trends affecting the growth of the market
• To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders